Motley Fool

20 Jul Stock Analysis

The chipmaker is about to enter a lucrative gaming niche.

20 Jul Stock Analysis

With many stocks trading at all-time highs, some investors question whether they should be putting more money into the…

20 Jul Stock Analysis

The FDA doesn’t appear to be impressed by the biotech’s experimental kidney disease drug.

20 Jul Stock Analysis

The satellite radio giant announces a $2 billion buyback. It didn’t work out so well last time.

20 Jul Stock Analysis

Legislation is starting to open up the industry but investors who are hoping to cash in on its growth…

20 Jul Stock Analysis

The stocks come pre-vetted by the best in the business.

20 Jul Stock Analysis

If your kids’ immediate needs are covered, these stocks could help build a nest egg for their future.

19 Jul Stock Analysis

What you need to know.

19 Jul Stock Analysis

Reading through your comments, questions, and stories from the month of June.

19 Jul Stock Analysis

The first half has been a cycle of hope and disappointment for shareholders.